Dolby Laboratories (DLB) Set to Announce Quarterly Earnings on Tuesday

Dolby Laboratories (NYSE:DLB – Get Free Report) will likely be issuing its Q4 2026 results after the market closes on Tuesday, November 17th. Analysts expect the company to post earnings of $1.19 per share and revenue of $372.76 million for the quarter. Individuals may review the information on the company’s upcoming Q4 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 17, 2026 at 5:00 PM ET.

Dolby Laboratories Stock Performance

DLB opened at $63.62 on Monday. Dolby Laboratories has a fifty-two week low of $48.26 and a fifty-two week high of $69.95. The firm’s fifty day moving average is $60.99 and its 200 day moving average is $59.43. The stock has a market cap of $5.96 billion, a price-to-earnings ratio of 27.07 and a beta of 0.78.

Dolby Laboratories announced that its Board of Directors has initiated a share buyback program on Thursday, July 30th that allows the company to repurchase $350 million in outstanding shares. This repurchase authorization allows the electronics maker to repurchase up to 7% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.

Insider Activity at Dolby Laboratories

In other news, CAO Ryan Nicholson sold 1,183 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total transaction of $77,226.24. Following the sale, the chief accounting officer owned 34,453 shares in the company, valued at $2,249,091.84. This trade represents a 3.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP John Couling sold 7,667 shares of the business’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total transaction of $450,666.26. Following the completion of the transaction, the senior vice president directly owned 166,803 shares in the company, valued at $9,804,680.34. This trade represents a 4.39% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 16,517 shares of company stock worth $995,963. Company insiders own 37.93% of the company’s stock.

Wall Street Analyst Weigh In

DLB has been the topic of a number of recent analyst reports. Weiss Ratings raised Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, September 9th. Rosenblatt Securities restated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday, August 28th. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, Zacks Research cut Dolby Laboratories from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 15th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Dolby Laboratories currently has an average rating of “Hold” and a consensus price target of $87.50.

View Our Latest Report on DLB

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

Read More

Earnings History for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.